ARGX
ARGENX SE
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 9/29/2026 | View on SEC |
| 6-K | 8/27/2026 | View on SEC |
| SC TO-T/A | 8/27/2026 | View on SEC |
| SC TO-T/A | 8/19/2026 | View on SEC |
| 6-K | 8/17/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SC TO-T/A | 8/6/2026 | View on SEC |
| SC TO-T | 8/6/2026 | View on SEC |
| 6-K | 8/3/2026 | View on SEC |
| SC TO-C | 7/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ARGX |
| Company Name | ARGENX SE |
| CIK | 1697862 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | P7 |
| Phone | 32 (9) 310 34 00 |